Slater & Gordon support medical research

Slater & Gordon support medical research

Initial focus on asbestos widened, with $2 million on offer.

Consumer law firm Slater & Gordon (S&G) will back research and education into public health with a new grant program.

The S&G Health Projects and Research Fund hopes to supply $2 million worth of grants for non-profit and allied health groups by 2020.

Managing director Andrew Grech says the program will benefit people suffering a catastrophic injury, disability or illness.

“We believe that beyond the individuals we represent, the firm can also play a broader role in advocating for people with asbestos and occupation-caused cancer and those who live with significant disability,” he says.

Grech says the program extends on S&G’s Asbestos Research Fund (ARF), which has donated more than $1.4 million to medical research.

""The work of the ARF, including the Vojakovic Fellowship program, will continue.

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

A game changer? Aspiring to the new standard on workplace mental health
Partner Content
Work health and safety regulators have been more active in the area of mental health ri...
Aon
Advertisement

Related Stories

Cyborg Dynamics Engineering secures $3.3m deal for Australia-first unmanned ground vehicle

Cyborg Dynamics Engineering secures $3.3m deal for Australia-first unmanned ground vehicle

Brisbane-based robotics and AI company Cyborg Dynamics Engineering ...

ASIC takes insurance giant to task over allegedly failing to apply $60m in promised discounts

ASIC takes insurance giant to task over allegedly failing to apply $60m in promised discounts

Australia’s corporate watchdog has Insurance Australia Limite...

NSW eases border restrictions with ACT and Queensland

NSW eases border restrictions with ACT and Queensland

As the Australian Capital Territory leaves lockdown today and Queen...

Pfizer jab closer to approval for children, IDT to make new Monash vaccine

Pfizer jab closer to approval for children, IDT to make new Monash vaccine

Australian children aged five to 11 years of age could receive Pfiz...